| 1 |
35008977 | Biological Evaluation and Molecular Docking Studies of Novel 1,3,4-Oxadiazole Derivatives of 4,6-Dimethyl-2-sulfanylpyridine-3-carboxamide. | 2022 Jan 4 |
2 |
| 2 |
35070636 | Synthesis, Spectroscopic and Biological Investigation of a New Ca(II) Complex of Meloxicam as Potential COX-2 Inhibitor. | 2022 |
1 |
| 3 |
35237322 | Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway. | 2022 |
1 |
| 4 |
35389917 | Meloxicam versus Celecoxib for Postoperative Analgesia after Total Knee Arthroplasty: Safety, Efficacy and Cost. | 2022 Apr 5 |
1 |
| 5 |
32721780 | Design, synthesis, biological evaluation and in silico studies of novel pyrrolo[3,4-d]pyridazinone derivatives withpromising anti-inflammatory and antioxidant activity. | 2020 Sep |
2 |
| 6 |
33266208 | New 1,3,4-Oxadiazole Derivatives of Pyridothiazine-1,1-Dioxide with Anti-Inflammatory Activity. | 2020 Nov 30 |
1 |
| 7 |
33348757 | Design, Synthesis and Comprehensive Investigations of Pyrrolo[3,4-d]pyridazinone-Based 1,3,4-Oxadiazole as New Class of Selective COX-2 Inhibitors. | 2020 Dec 17 |
1 |
| 8 |
29174987 | Drug-excipient compatibility assessment of solid formulations containing meloxicam. | 2018 Jan 15 |
1 |
| 9 |
28353025 | Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs. | 2017 Oct |
1 |
| 10 |
29030657 | Meloxicam and risk of myocardial infarction: a population-based nested case-control study. | 2017 Dec |
1 |
| 11 |
25429611 | Involvement of prolactin in the meloxicam-dependent inflammatory response of the gonadotropic axis to prolonged lipopolysaccharide treatment in anoestrous ewes. | 2016 Jun |
1 |
| 12 |
26826540 | Inflammatory mechanisms contribute to microembolism-induced anxiety-like and depressive-like behaviors. | 2016 Apr 15 |
1 |
| 13 |
27109804 | Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway. | 2016 Jun |
3 |
| 14 |
27479158 | Cyclooxygenase Inhibitors as a New Therapeutic Strategy in Small Bowel Transplantation. | 2016 Nov |
1 |
| 15 |
27523985 | Effects of NSAIDs on the osteogenic differentiation of human adipose tissue-derived stromal cells. | 2016 Nov |
1 |
| 16 |
27687548 | NSAIDs diclofenac, indomethacin, and meloxicam highly upregulate expression of ICAM-1 and COX-2 induced by X-irradiation in human endothelial cells. | 2016 Oct 28 |
3 |
| 17 |
25515365 | The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review. | 2015 Feb |
1 |
| 18 |
25899770 | Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status. | 2015 Dec |
1 |
| 19 |
26600514 | Meloxicam increases intracellular accumulation of doxorubicin via downregulation of multidrug resistance-associated protein 1 (MRP1) in A549 cells. | 2015 Nov 19 |
2 |
| 20 |
23298324 | Development of meloxicam in situ implant formulation by quality by design principle. | 2014 Jan |
1 |
| 21 |
24425867 | Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network. | 2014 Mar 7 |
5 |
| 22 |
24675684 | Meloxicam executes its antitumor effects against hepatocellular carcinoma in COX-2- dependent and -independent pathways. | 2014 |
9 |
| 23 |
25255073 | Pharmacokinetics of 3 formulations of meloxicam in cynomolgus macaques (Macaca fascicularis). | 2014 Sep |
1 |
| 24 |
25271421 | Meloxicam blocks neuroinflammation, but not depressive-like behaviors, in HIV-1 transgenic female rats. | 2014 |
1 |
| 25 |
23031659 | Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity? | 2013 May-Jun |
1 |
| 26 |
22348284 | Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells. | 2012 Sep |
1 |
| 27 |
23480764 | Anti-inflammatory agents suppress the prostaglandin E2 production and migration ability of cholangiocarcinoma cell lines. | 2012 |
1 |
| 28 |
24213228 | Transition of treatment for patients with extra-abdominal desmoid tumors: nagoya university modality. | 2012 Feb 7 |
1 |
| 29 |
19963049 | Effective antiproliferative effect of meloxicam on prostate cancer cells: development of a new controlled release system. | 2010 Mar 15 |
1 |
| 30 |
20580659 | Peripheral and central cyclooxygenase (COX) products may contribute to the manifestation of brain-controlled sickness responses during localized inflammation induced by macrophage-activating lipopeptide-2 (MALP-2). | 2010 Jul 26 |
1 |
| 31 |
20651346 | COX-2 expression and effects of COX-2 inhibition in colorectal carcinomas and their liver metastases. | 2010 Jun |
1 |
| 32 |
20840388 | In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study. | 2010 Oct |
1 |
| 33 |
18499296 | A phase II study of carboplatin and paclitacel with meloxicam. | 2009 Jan |
1 |
| 34 |
19203564 | Comparison of the efficacy and safety of a novel meloxicam ophthalmic formulation with a reference diclofenac solution in cataract surgery. | 2009 Feb |
1 |
| 35 |
19602986 | Variability in the response to cyclooxygenase inhibitors: toward the individualization of nonsteroidal anti-inflammatory drug therapy. | 2009 Aug |
1 |
| 36 |
19642502 | [Efficacy of meloxicam in juvenile polyposis syndrome. A case report]. | 2009 Mar-Apr |
1 |
| 37 |
19709125 | Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice. | 2009 Nov |
1 |
| 38 |
18058818 | The effects of a COX-2 inhibitor meloxicam on squamous cell carcinoma of the esophagus in vivo. | 2008 Apr 1 |
3 |
| 39 |
18403118 | Cyclooxygenase-2 is involved in oxidative damage and alpha-synuclein accumulation in dopaminergic cells. | 2008 May 9 |
4 |
| 40 |
18516356 | Review of the cardiovascular safety of COXIBs compared to NSAIDS. | 2008 Mar-Apr |
1 |
| 41 |
19024285 | [Meloxicam--the balance of efficacy and safety]. | 2008 |
1 |
| 42 |
17164136 | Pharmacodynamic of cyclooxygenase inhibitors in humans. | 2007 Jan |
1 |
| 43 |
17340600 | Osteoblast response to fluid induced shear depends on substrate microarchitecture and varies with time. | 2007 Oct |
2 |
| 44 |
17447009 | Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells. | 2007 Oct |
4 |
| 45 |
16462098 | Preparation and evaluation of solid dispersion of meloxicam with skimmed milk. | 2006 Feb |
1 |
| 46 |
17017983 | Interactions between oxicams and membrane bilayers: an explanation for their different COX selectivity. | 2006 Sep |
2 |
| 47 |
17154669 | Use of nonsteroidal anti-inflammatory drugs in patients with aspirin hypersensitivity : safety of cyclo-oxygenase-2 inhibitors. | 2006 |
1 |
| 48 |
15827035 | A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines. | 2005 Jul |
1 |
| 49 |
15892673 | The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. | 2005 |
1 |
| 50 |
16021964 | [The selective cox-2 inhibitor meloxicam and salicylate therapy]. | 2005 May 20 |
1 |